Tuesday morning showed a tale of two companies. Novo Nordisk (NVO) sold off more than 20% after making heavy reductions to sales guidance for its Ozempic and Wegovy weight loss drugs. Meanwhile, SoFi Technologies (SOFI) climbed with a strong showing in its fintech earnings. Jenny Horne goes over the biggest morning movers before the opening bell.